Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30058638HIVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS30020716HIVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS30058639HIVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS20036587HPVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS20023553HPVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TCGA Plot Options
Drug Information
GeneP2RY12
DrugBank IDDB00208
Drug NameTiclopidine
Target IDBE0000110
UniProt IDQ9H244
Regulation Typeantagonist
PubMed IDs11454254; 15816504; 15955565; 17110146; 11752352
CitationsStorey RF: The P2Y12 receptor as a therapeutic target in cardiovascular disease. Platelets. 2001 Jun;12(4):197-209.@@Boeynaems JM, van Giezen H, Savi P, Herbert JM: P2Y receptor antagonists in thrombosis. Curr Opin Investig Drugs. 2005 Mar;6(3):275-82.@@Gachet C: The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Pharmacol Ther. 2005 Nov;108(2):180-92. Epub 2005 Jun 13.@@Zhan C, Yang J, Dong XC, Wang YL: Molecular modeling of purinergic receptor P2Y12 and interaction with its antagonists. J Mol Graph Model. 2007 Jul;26(1):20-31. Epub 2006 Sep 26.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved
Direct ClassificationThienopyridines
SMILESClC1=CC=CC=C1CN1CCC2=C(C1)C=CS2
PathwaysTiclopidine Action Pathway; Ticlopidine Metabolism Pathway
PharmGKBPA451686
ChEMBLCHEMBL833